Aggregated News

What are the chances that the prestigious Institute of Medicine will get an objective and balanced view of California’s stem-cell program when it takes public testimony about the program at a hearing Tuesday in San Francisco?
About 418 million to one.

That’s the estimation of the California Stem Cell Report. The report’s proprietor, David Jensen, toted up the value of the grants received from the program by Tuesday’s witnesses or their employers. Total: $418 million.

The IOM was given a $700,000 contract by the stem-cell program, which is formally known as the California Institute for Regenerative Medicine and was created by Proposition 71 in 2004, to look at its record. CIRM clearly hoped for a glowing review to help it pitch for another infusion of bond-issue cash from California voters to add to the $3 billion authorized by Prop 71.

There's been no dearth of criticism of CIRM since its inception: questions about conflicts of interest among its board members, about whether it's spending its billions wisely, about whether its narrow focus on stem-cell research is scientifically too narrow.

As...